X-17800602-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_021785.6(RAI2):āc.1409G>Cā(p.Arg470Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000126 in 1,209,875 control chromosomes in the GnomAD database, including 2 homozygotes. There are 37 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00039 ( 1 hom., 9 hem., cov: 23)
Exomes š: 0.000099 ( 1 hom. 28 hem. )
Consequence
RAI2
NM_021785.6 missense
NM_021785.6 missense
Scores
3
4
10
Clinical Significance
Conservation
PhyloP100: 5.46
Genes affected
RAI2 (HGNC:9835): (retinoic acid induced 2) Retinoic acid plays a critical role in development, cellular growth, and differentiation. The specific function of this retinoic acid-induced gene has not yet been determined but it may play a role in development. The chromosomal location of this gene designates it to be a candidate for diseases such as Nance-Horan syndrome, sensorineural deafness, non-specific X-linked cognitive disability, oral-facial-digital syndrome, and Fried syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2635985).
BS2
High Hemizygotes in GnomAd4 at 9 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RAI2 | NM_021785.6 | c.1409G>C | p.Arg470Thr | missense_variant | 2/2 | ENST00000451717.6 | NP_068557.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RAI2 | ENST00000451717.6 | c.1409G>C | p.Arg470Thr | missense_variant | 2/2 | 1 | NM_021785.6 | ENSP00000401323 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000394 AC: 44AN: 111779Hom.: 1 Cov.: 23 AF XY: 0.000265 AC XY: 9AN XY: 33947
GnomAD3 genomes
AF:
AC:
44
AN:
111779
Hom.:
Cov.:
23
AF XY:
AC XY:
9
AN XY:
33947
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000180 AC: 33AN: 183387Hom.: 1 AF XY: 0.0000885 AC XY: 6AN XY: 67829
GnomAD3 exomes
AF:
AC:
33
AN:
183387
Hom.:
AF XY:
AC XY:
6
AN XY:
67829
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000993 AC: 109AN: 1098043Hom.: 1 Cov.: 30 AF XY: 0.0000770 AC XY: 28AN XY: 363403
GnomAD4 exome
AF:
AC:
109
AN:
1098043
Hom.:
Cov.:
30
AF XY:
AC XY:
28
AN XY:
363403
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000393 AC: 44AN: 111832Hom.: 1 Cov.: 23 AF XY: 0.000265 AC XY: 9AN XY: 34010
GnomAD4 genome
AF:
AC:
44
AN:
111832
Hom.:
Cov.:
23
AF XY:
AC XY:
9
AN XY:
34010
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
23
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 04, 2023 | The c.1409G>C (p.R470T) alteration is located in exon 3 (coding exon 1) of the RAI2 gene. This alteration results from a G to C substitution at nucleotide position 1409, causing the arginine (R) at amino acid position 470 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T;T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;.;.;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;L;L
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D;D
REVEL
Benign
Sift
Pathogenic
D;D;D;D;D
Sift4G
Uncertain
D;T;T;T;T
Polyphen
1.0
.;D;D;D;D
Vest4
MVP
MPC
0.20
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at